Crystalline pharmaceutical and methods of preparation and use thereof
US8367701B2 · kind B2 · utility
29Cited by
62References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2011 |
| Grant date | Feb 5, 2013 |
| Priority date | — |
| Expiry date | Nov 4, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/183
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.